Approval · Notice of Compliance 37466 · 2026
HEMABATE: Notice of Compliance 37466
Issued May 1, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37466
- Date
- May 1, 2026
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the composition of a dosage form. Addition of a drug product manufacturing site and/or manufacturer involving production. Addition of a drug product manufacturing site and/or manufacturer involving primary packaging. Addition of a drug product manufacturing site and/or manufacturer involving testing. Change in the batch size for the drug product. Change in the drug product manufacturing process. Change in the specification for the drug product. Update to package labels. Update to package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HEMABATE | Not yet assigned | — |
Medicinal ingredients
- CARBOPROST TROMETHAMINE 250 MCG per ML